Scientific Research An Academic Publisher
OPEN ACCESS
Add your e-mail address to receive free newsletters from SCIRP.
Select Journal AA AAD AAR AASoci AAST ABB ABC ABCR ACES ACS ACT AD ADR AE AER AHS AID AiM AIT AJAC AJC AJCC AJCM AJIBM AJMB AJOR AJPS ALAMT ALC ALS AM AMI AMPC ANP APD APE APM ARS ARSci AS ASM BLR CC CE CellBio ChnStd CM CMB CN CRCM CS CSTA CUS CWEEE Detection EMAE ENG EPE ETSN FMAR FNS GEP GIS GM Graphene GSC Health IB ICA IIM IJAA IJAMSC IJCCE IJCM IJCNS IJG IJIDS IJIS IJMNTA IJMPCERO IJNM IJOC IJOHNS InfraMatics JACEN JAMP JASMI JBBS JBCPR JBiSE JBM JBNB JBPC JCC JCDSA JCPT JCT JDAIP JDM JEAS JECTC JEMAA JEP JFCMV JFRM JGIS JHEPGC JHRSS JIBTVA JILSA JIS JMF JMGBND JMMCE JMP JPEE JQIS JSBS JSEA JSEMAT JSIP JSS JSSM JST JTR JTST JTTs JWARP LCE MC ME MI MME MNSMS MPS MR MRC MRI MSA MSCE NJGC NM NR NS OALib OALibJ ODEM OJA OJAB OJAcct OJAnes OJAP OJApo OJAppS OJAPr OJAS OJBD OJBIPHY OJBM OJC OJCB OJCD OJCE OJCM OJD OJDer OJDM OJE OJEE OJEM OJEMD OJEpi OJER OJF OJFD OJG OJGas OJGen OJI OJIC OJIM OJINM OJL OJM OJMC OJMetal OJMH OJMI OJMIP OJML OJMM OJMN OJMP OJMS OJMSi OJN OJNeph OJO OJOG OJOGas OJOp OJOph OJOPM OJOTS OJPathology OJPC OJPChem OJPed OJPM OJPP OJPS OJPsych OJRA OJRad OJRD OJRM OJS OJSS OJSST OJST OJSTA OJTR OJTS OJU OJVM OPJ POS PP PST PSYCH SAR SCD SGRE SM SN SNL Soft SS TEL TI UOAJ VP WET WJA WJCD WJCMP WJCS WJET WJM WJNS WJNSE WJNST WJV WSN YM
More>>
Matsumura, Y. and Maeda, H. (1986) A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Research, 46, 6387-6392.
has been cited by the following article:
TITLE: Current Possible Drug Therapies for Ovarian Cancer
AUTHORS: Jungyeob Seoung, Young-Han Park, Chaechun Rhim, Sungju Kim
KEYWORDS: Ovarian Cancer, Intraperitoneal Chemotherapy, Targeting Therapy
JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.13, November 7, 2014
ABSTRACT: Ovarian cancer is the most aggressive gynecologic cancer of the heterogenous phenotypes. Development of the new chemotherapeutic agents and drug delivery mode makes better outcomes for patient treatments. Optimal cytoreductive therapy followed by molecular targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is a hot therapeutic concept in ovarian cancers. In our review, we will introduce recent therapeutic advances in epithelial ovarian cancer patients.
Related Articles:
Predicting Adjuvant Chemotherapy Outcome by Simultaneous Analysis of Thymidylate Synthase Expression and p53 Nuclear Accumulation in Colorectal Cancer
Zihuan Yang, Dandan Huang, Lekun Fang, Xingzhi Feng, Huanliang Liu, Lei Wang, Jianping Wang
DOI: 10.4236/jct.2015.65048 2,648 Downloads 3,044 Views Citations
Pub. Date: May 27, 2015
Cancer as a Therapeutic Agent?
Mario Gosalvez
DOI: 10.4236/jct.2013.48161 4,323 Downloads 5,394 Views Citations
Pub. Date: October 29, 2013
Autophagic cell death: A new frontier in cancer research
S. Zappavigna, A. Luce, G. Vitale, N. Merola, S. Facchini, M. Caraglia
DOI: 10.4236/abb.2013.42034 5,016 Downloads 8,456 Views Citations
Pub. Date: February 28, 2013
Monoclonal Antibodies: An Emerging Class of Therapeutics in Non Small Cell Lung Cancer
L. Guilleminault, E. Lemarié, N. Heuzé-Vourc’h
DOI: 10.4236/jct.2012.36153 3,724 Downloads 6,368 Views Citations
Pub. Date: December 27, 2012
Biomarker Driven Cancer Therapeutics: Existing Tools and Remaining Gaps
Sasi Shanmugam Senga, Jemma Arakelyan
DOI: 10.4236/oalib.1106556 167 Downloads 420 Views Citations
Pub. Date: July 31, 2020
